Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Vestibular dysfunction and the development of therapies for Usher syndrome

Award Number: R01DC020243
ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/01/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2027

Group Awards By:

View Award Description

Vestibular dysfunction and the development of therapies for Usher syndrome - Project Summary Collectively, rare diseases affect ~350 million people in the world, and most of them lack specific treatments resulting in a tremendous unmet medical need. Understanding the underlying genetic and molecular mechanisms and developing therapies for rare diseases are essential for our efforts to address this urgent need. The present application focuses on understanding and treating Usher syndrome (Usher), a rare disease characterized by multisensory loss (hearing, vision, and balance) that creates a major communication and mobility burden affecting all aspects of life. Currently, there are no treatments to prevent or slow the progression of Usher. To fill these important gaps, we propose three aims in this collaborative project to determine the progression of vestibular dysfunction over time in the knock-in mouse model for the most common type 1 Usher mutation in the Acadian populations of Louisiana and Canada (USH1C c.216G>A) (Aim 1) and in a cohort of pediatric, young adult, and adult USH1C patients (Aim 3), and to test the therapeutic efficacies of antisense and gene replacement therapies when delivered at different stages of disease progression in the USH1C mice (Aim 2). These aims are driven by the central hypothesis that USH1C-related vestibular dysfunction progresses over time and is end-organ specific, which is supported by our strong preliminary studies that show age-dependent declines of the vestibulo-ocular reflexes, and progressive saccular hair cell degeneration in USH1C mice. In Aim 1, we will employ a combination of molecular, structural, single vestibular afferent neurophysiology, and behavioral biomarkers to define the progression of vestibular dysfunction in USH1C mice over a 1-year time course. In Aim 2, we will continue studies to restoring vestibular function in neonatal USH1C mice using the antisense and gene replacement therapies and further test their effectiveness when delivered at various stages of disease progression. In parallel, in Aim 3, we will define the natural history of vestibular dysfunction in a cohort of 50 USH1C patients by testing their vestibular function at baseline and 6 months later. These results will fill the important gaps in understanding and treating Usher disease and allow us to define the clinical outcome measures for future clinical trials. Results from this collaborative project will identify lead clinical drug candidates, an optimal treatment regimen for restoring vestibular function in USH1C mice, and define measurable clinical outcomes to guide a first-in-human study of a treatment for vestibular dysfunction in USH1C.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $631,738 )
2026	2026	LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS	433 BOLIVAR ST RM 619	NEW ORLEANS	LA	70112	ORLEANS	USA	Research Related to Deafness and Communication Disorders	001	4	2/10/2026	NON-COMPETING CONTINUATION	$63,173
2026	2026	LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS	433 BOLIVAR ST RM 619	NEW ORLEANS	LA	70112	ORLEANS	USA	Research Related to Deafness and Communication Disorders	000	4	12/17/2025	NON-COMPETING CONTINUATION	$568,565
														Subtotal = $631,738

Issue Date FY: 2025 ( Subtotal = $635,126 )
2025	2025	LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS	433 BOLIVAR ST RM 619	NEW ORLEANS	LA	70112	ORLEANS	USA	Research Related to Deafness and Communication Disorders	001	3	4/29/2025	NON-COMPETING CONTINUATION	$63,512
2025	2025	LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS	433 BOLIVAR ST RM 619	NEW ORLEANS	LA	70112	ORLEANS	USA	Research Related to Deafness and Communication Disorders	000	3	12/17/2024	NON-COMPETING CONTINUATION	$571,614
														Subtotal = $635,126

Issue Date FY: 2024 ( Subtotal = $638,418 )
2024	2024	LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS	433 BOLIVAR ST RM 619	NEW ORLEANS	LA	70112	ORLEANS	USA	Research Related to Deafness and Communication Disorders	000	2	1/5/2024	NON-COMPETING CONTINUATION	$574,577
2024	2024	LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS	433 BOLIVAR ST RM 619	NEW ORLEANS	LA	70112	ORLEANS	USA	Research Related to Deafness and Communication Disorders	001	2	5/2/2024	NON-COMPETING CONTINUATION	$63,841
														Subtotal = $638,418

Issue Date FY: 2023 ( Subtotal = $665,113 )
2023	2023	LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER-NEW ORLEANS	433 BOLIVAR ST STE 815	NEW ORLEANS	LA	70112	ORLEANS	USA	Research Related to Deafness and Communication Disorders	000	1	12/19/2022	NEW	$665,113
														Subtotal = $665,113

Grand Total All Awards = $2,570,395

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Vestibular dysfunction and the development of therapies for Usher syndrome

Award Number: R01DC020243

ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/01/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer